Similar articles

• Infectious disease. An enterprising time for HIV vaccine research.

  Cohen J. Cohen J. Science. 2012 Sep 21;337(6101):1446. doi: 10.1126/science.337.6101.1446. Science. 2012. PMID: 22997300 No abstract available.
• DNA vaccines for immunodeficiency viruses.

  Robinson HL. Robinson HL. AIDS. 1997;11 Suppl A:S109-19. AIDS. 1997. PMID: 9451974 Review. No abstract available.
• [Monoclonal anti-HIV antibodies in HIV/AIDS research. Diagnosis and therapy].

  Giese R, Grunow R. Giese R, et al. Allerg Immunol (Leipz). 1989;35(1):25-37. Allerg Immunol (Leipz). 1989. PMID: 2718887 German.
• Fc receptor but not complement binding is important in antibody protection against HIV.

  Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, Bakker JM, Lanigan CM, Landucci G, Forthal DN, Parren PW, Marx PA, Burton DR. Hessell AJ, et al. Nature. 2007 Sep 6;449(7158):101-4. doi: 10.1038/nature06106. Nature. 2007. PMID: 17805298
• Challenges and opportunities for development of an AIDS vaccine.

  Nabel GJ. Nabel GJ. Nature. 2001 Apr 19;410(6831):1002-7. doi: 10.1038/35073500. Nature. 2001. PMID: 11309631 Review.